251 related articles for article (PubMed ID: 21422164)
21. Heteromer Induction: An Approach to Unique Pharmacology?
Portoghese PS; Akgün E; Lunzer MM
ACS Chem Neurosci; 2017 Mar; 8(3):426-428. PubMed ID: 28139906
[TBL] [Abstract][Full Text] [Related]
22. Mu and delta opioid receptor knockout mice show increased colonic sensitivity.
Reiss D; Ceredig RA; Secher T; Boué J; Barreau F; Dietrich G; Gavériaux-Ruff C
Eur J Pain; 2017 Apr; 21(4):623-634. PubMed ID: 27748566
[TBL] [Abstract][Full Text] [Related]
23. Opioid receptor heteromers in analgesia.
Costantino CM; Gomes I; Stockton SD; Lim MP; Devi LA
Expert Rev Mol Med; 2012 Apr; 14():e9. PubMed ID: 22490239
[TBL] [Abstract][Full Text] [Related]
24. Mu and delta opioid receptor immunoreactivity and mu receptor regulation in brainstem cells cultured from late fetal and early postnatal rats.
Kivell BM; Day DJ; McDonald FJ; Miller JH
Brain Res Dev Brain Res; 2004 Mar; 149(1):9-19. PubMed ID: 15013624
[TBL] [Abstract][Full Text] [Related]
25. Further Optimization and Evaluation of Bioavailable, Mixed-Efficacy μ-Opioid Receptor (MOR) Agonists/δ-Opioid Receptor (DOR) Antagonists: Balancing MOR and DOR Affinities.
Harland AA; Yeomans L; Griggs NW; Anand JP; Pogozheva ID; Jutkiewicz EM; Traynor JR; Mosberg HI
J Med Chem; 2015 Nov; 58(22):8952-69. PubMed ID: 26524472
[TBL] [Abstract][Full Text] [Related]
26. Heteromers of μ-δ opioid receptors: new pharmacology and novel therapeutic possibilities.
Fujita W; Gomes I; Devi LA
Br J Pharmacol; 2015 Jan; 172(2):375-87. PubMed ID: 24571499
[TBL] [Abstract][Full Text] [Related]
27. Preferential cytoplasmic localization of delta-opioid receptors in rat striatal patches: comparison with plasmalemmal mu-opioid receptors.
Wang H; Pickel VM
J Neurosci; 2001 May; 21(9):3242-50. PubMed ID: 11312309
[TBL] [Abstract][Full Text] [Related]
28. Tuned-Affinity Bivalent Ligands for the Characterization of Opioid Receptor Heteromers.
Harvey JH; Long DH; England PM; Whistler JL
ACS Med Chem Lett; 2012 Aug; 3(8):640-644. PubMed ID: 23585918
[TBL] [Abstract][Full Text] [Related]
29. Identity of the putative delta1-opioid receptor as a delta-kappa heteromer in the mouse spinal cord.
Portoghese PS; Lunzer MM
Eur J Pharmacol; 2003 Apr; 467(1-3):233-4. PubMed ID: 12706480
[TBL] [Abstract][Full Text] [Related]
30. Interaction of co-expressed mu- and delta-opioid receptors in transfected rat pituitary GH(3) cells.
Martin NA; Prather PL
Mol Pharmacol; 2001 Apr; 59(4):774-83. PubMed ID: 11259622
[TBL] [Abstract][Full Text] [Related]
31. Development and in vitro characterization of a novel bifunctional μ-agonist/δ-antagonist opioid tetrapeptide.
Purington LC; Sobczyk-Kojiro K; Pogozheva ID; Traynor JR; Mosberg HI
ACS Chem Biol; 2011 Dec; 6(12):1375-81. PubMed ID: 21958158
[TBL] [Abstract][Full Text] [Related]
32. Co-expression of mu and delta opioid receptors as receptor-G protein fusions enhances both mu and delta signalling via distinct mechanisms.
Snook LA; Milligan G; Kieffer BL; Massotte D
J Neurochem; 2008 May; 105(3):865-73. PubMed ID: 18182056
[TBL] [Abstract][Full Text] [Related]
33. Emergence of functional spinal delta opioid receptors after chronic ethanol exposure.
van Rijn RM; Brissett DI; Whistler JL
Biol Psychiatry; 2012 Feb; 71(3):232-8. PubMed ID: 21889123
[TBL] [Abstract][Full Text] [Related]
34. mu-Opioid receptors desensitize less rapidly than delta-opioid receptors due to less efficient activation of arrestin.
Lowe JD; Celver JP; Gurevich VV; Chavkin C
J Biol Chem; 2002 May; 277(18):15729-35. PubMed ID: 11861651
[TBL] [Abstract][Full Text] [Related]
35. The benzomorphan-based LP1 ligand is a suitable MOR/DOR agonist for chronic pain treatment.
Pasquinucci L; Parenti C; Turnaturi R; Aricò G; Marrazzo A; Prezzavento O; Ronsisvalle S; Georgoussi Z; Fourla DD; Scoto GM; Ronsisvalle G
Life Sci; 2012 Jan; 90(1-2):66-70. PubMed ID: 22100511
[TBL] [Abstract][Full Text] [Related]
36. Mu-opioid receptor and delta-opioid receptor differentially regulate microglial inflammatory response to control proopiomelanocortin neuronal apoptosis in the hypothalamus: effects of neonatal alcohol.
Shrivastava P; Cabrera MA; Chastain LG; Boyadjieva NI; Jabbar S; Franklin T; Sarkar DK
J Neuroinflammation; 2017 Apr; 14(1):83. PubMed ID: 28407740
[TBL] [Abstract][Full Text] [Related]
37. Prolonged morphine treatment alters δ opioid receptor post-internalization trafficking.
Ong EW; Xue L; Olmstead MC; Cahill CM
Br J Pharmacol; 2015 Jan; 172(2):615-29. PubMed ID: 24819092
[TBL] [Abstract][Full Text] [Related]
38. Evidence and Function Relevance of Native DOR-MOR Heteromers.
Cahill CM; Ong E
Handb Exp Pharmacol; 2018; 247():115-127. PubMed ID: 29633181
[TBL] [Abstract][Full Text] [Related]
39. Putative kappa opioid heteromers as targets for developing analgesics free of adverse effects.
Le Naour M; Lunzer MM; Powers MD; Kalyuzhny AE; Benneyworth MA; Thomas MJ; Portoghese PS
J Med Chem; 2014 Aug; 57(15):6383-92. PubMed ID: 24978316
[TBL] [Abstract][Full Text] [Related]
40. Constitutive Desensitization of Opioid Receptors in Peripheral Sensory Neurons.
Sullivan LC; Chavera TS; Jamshidi RJ; Berg KA; Clarke WP
J Pharmacol Exp Ther; 2016 Dec; 359(3):411-419. PubMed ID: 27660244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
